New hope for tough blood cancers: experimental drug combo enters human testing
NCT ID NCT06656494
Summary
This early-stage study is testing a new drug called ICP-248, given alongside an existing drug (azacitidine), for adults with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goals are to find a safe dose and see how well the body handles the combination. Researchers will also look for early signs that the treatment might help control these serious blood cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOGENOUS LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospita
RECRUITINGHefei, Anhui, 230001, China
Contact Email: •••••@•••••
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, 510030, China
Contact Email: •••••@•••••
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanfang Hospital Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
Contact Email: •••••@•••••
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shengjing Hospital of China Medical University
RECRUITINGShengyang, Liaoning, 110004, China
Contact Email: •••••@•••••
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 400042, China
Contact Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310012, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130000, China
Contact Email: •••••@•••••
-
Tianjin People's Hospital
RECRUITINGTianjin, Tianjin Municipality, 300192, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.